Business
Director Disclosure
Director Disclosure.
About this update from Caledonian Holdings Plc.
[{"type":"text","content":"\n \n \n \n RNS Number : 0865M\n Vela Technologies PLC\n 18 January 2021\n \n \n \n \n Vela Technologies plc\n \n \n (\"Vela\" or \"the Company\")\n \n \n \n Director Disclosure\n \n \n James Normand, Executive Director of Vela, has advised the Company that, on 21 December 2020, the creditors of Global Resources Investment Trust PLC, of which he is a director, approved a Company Voluntary Arrangement.\n \n \n \n \n \n This announcement is made in accordance with Rule 17 and schedule 2, paragraph (g) of the AIM Rules for Companies.\n \n \n \n \n \n For further information, please contact:\n \n \n \n \n \n Vela Technologies plc\n \n \n Brent Fitzpatrick, Non-Executive Chairman\n \n \n James Normand, Executive Director\n \n \n \n \n \n \n \n Tel: +44 (0) 7421 728875\n \n \n \n \n \n \n Allenby Capital Limited (Nominated Adviser and Joint Broker)\n \n \n \n \n Tel: +44 (0) 20 3328 5656\n \n \n \n \n \n \n Nick Athanas/Asha Chotai\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Peterhouse Capital Limited (Joint Broker)\n \n \n Lucy Williams / Duncan Vasey / Eran Zucker\n \n \n \n \n Tel: +44 (0) 20 7469 0930\n \n \n \n \n \n \n \n \n \n About Vela Technologies \n \n \n \n \n \n \n \n \n \n Vela Technologies (AIM: VELA) is an investing company focused on early stage and pre-IPO long term disruptive technology investments. Vela's investee companies have either developed ways of utilising technology or are developing technology with a view to disrupting the businesses or sector in which they operate. More recently, Vela Technologies has also started to focus on existing listed companies where valuations may offer additional opportunities.\n \n \n \n \n This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commerci...